Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Commercialising a smart cardiac implant platform for the treatment of chronic cardiovascular disease

Objectif

Every year chronic cardiac disease causes 3.9 million deaths in Europe, that’s a death every 8 seconds. Overall chronic cardiac disease is estimated to cost the EU €210 billion/yr, in direct healthcare costs. All chronic cardiac disease patients are at high risk of stroke, atrial fibrillation, &/or heart failure
The AuriGen platform is single minded in its focus on the leading causes of death in the developed world – Cardiovascular Diseases. Allowing more complex patients to be treated more effectively, and at a lower cost per patient.
AuriGen’s platform of 4 devices is built around our custom cardiac implant, to which we can add synergistic modules such as cardiac monitoring, ablation or both modules. Creating devices which are much more than the sum of their parts, this our key USP. Allowing AuriGen to efficiently & effectively manage the most expensive & sub-optimally treated patients, in a single, safe, fast minimally invasive procedure.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) HORIZON-EIC-2022-ACCELERATOR-01

Voir tous les projets financés au titre de cet appel

Coordinateur

AURIGEN MEDICAL LIMITED
Contribution nette de l'UE
€ 2 499 999,00
Adresse
18 CHURCHWELL SQUARE
DUBLIN 13 Dublin
Irlande
PME
Oui
Région
Ireland Eastern and Midland Dublin
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 3 999 999,75